Intravenous administration of tramadol
AssigneeRevogenex Ireland Ltd
InventorLucy Lu
Life of this patent
Estimating the term…
Abstract
A method of treating pain, e.g., acute post-operative pain, by administering to a human patient(s) a therapeutically effective dose of tramadol intravenously in a dosing regimen which includes one or more loading doses administered at shortened intervals as compared to dosing at steady-state is disclosed. In certain embodiments, the dose of tramadol about 25 mg and the second (and optionally) third doses are intravenously administered at intervals of about 2 hours, and thereafter the tramadol is intravenously administered at a dosing interval of about 4 hours, until the patient no longer requires treatment with tramadol.
Claims20
A method of administering tramadol for treating acute pain in a human patient(s) via an intravenous dosing regimen comprising
- intravenously administering a first dose of tramadol to a human patient(s) in an amount of about 25 mg;
- intravenously administering a second dose of tramadol to the human patient(s) in an amount of about 25 mg to about 50 mg at about 2 hours after the first dose;
- intravenously administering a third dose of tramadol to the human patient(s) in an amount of about 25 mg at about 2 hours after the second dose;
- and thereafter
- intravenously administering additional doses of tramadol to the human patient(s) in an amount of about 25 mg tramadol at dosage intervals of about 4 hours, until the patient no longer requires treatment with tramadol, wherein the tramadol is tramadol base or a pharmaceutically acceptable salt of tramadol.
A method of administering tramadol for treating acute pain in a human patient(s) via an intravenous dosing regimen comprising
- intravenously administering a first dose of tramadol to a human patient(s) in an amount of about 25 mg;
- intravenously administering a second dose of tramadol to the human patient(s) in an amount of about 25 mg at about 2 hours after the first dose;
- intravenously administering a third dose of tramadol to the human patient(s) in an amount of about 25 mg at about 2 hours after the second dose;
- and thereafter
- intravenously administering additional doses of tramadol to the human patient(s) in an amount of about 25 mg tramadol at dosage intervals of about 4 hours, until the patient no longer requires treatment with tramadol, wherein the tramadol is tramadol base or a pharmaceutically acceptable salt of tramadol.
A method of administering tramadol for treating pain in a human patient(s) via an intravenous dosing regimen comprising
- intravenously administering a first dose of tramadol to a human patient(s) in an amount of about 25 to less than 50 mg;
- intravenously administering a second dose of tramadol to the human patient(s) in an amount of about 25 mg to about 50 mg at about 2 hours after the first dose;
- intravenously administering a third dose of tramadol to the human patient(s) in an amount of about 25 mg to less than 50 mg at about 2 hours after the second dose;
- and thereafter
- intravenously administering additional doses of tramadol to the human patient(s) in an amount of about 25 mg to less than about 50 mg tramadol at dosage intervals of about 4 hours, until the patient no longer requires treatment with tramadol, wherein the tramadol is tramadol base or a pharmaceutically acceptable salt of tramadol.
Dependencies are inferred from the claim text.